Evidence map›Paper›PMID 36862556›Full record

ArticleCell reports2023

A cell-type-specific alternative splicing regulator shapes synapse properties in a trans-synaptic manner.

Lisa Traunmüller, Jan Schulz, Raul Ortiz, Huijuan Feng, Elisabetta Furlanis, Andrea M Gomez, Dietmar Schreiner, Josef Bischofberger, Chaolin Zhang, Peter Scheiffele

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Diverse Transcriptional Alterations in V2a Propriospinal Neurons Following Spinal Cord Injury.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. An impaired splicing program underlies differentiation defects in hSOD1Cellular and molecular life sciences : CMLS · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Lisa TraunmüllerBiozentrum of the University of Basel, 4056 Basel, Switzerland.
Jan SchulzDepartment of Biomedicine, University of Basel, 4056 Basel, Switzerland.
Raul OrtizBiozentrum of the University of Basel, 4056 Basel, Switzerland.
Huijuan FengDepartment of Systems Biology, Department of Biochemistry and Molecular Biophysics, Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
Elisabetta FurlanisBiozentrum of the University of Basel, 4056 Basel, Switzerland.
Andrea M GomezBiozentrum of the University of Basel, 4056 Basel, Switzerland.
Dietmar SchreinerBiozentrum of the University of Basel, 4056 Basel, Switzerland.
Josef BischofbergerDepartment of Biomedicine, University of Basel, 4056 Basel, Switzerland.
Chaolin ZhangDepartment of Systems Biology, Department of Biochemistry and Molecular Biophysics, Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
Peter ScheiffeleBiozentrum of the University of Basel, 4056 Basel, Switzerland. Electronic address: peter.scheiffele@unibas.ch.
University of Basel · CHColumbia University · US

Funding

Complexity and evolution of splicing-regulatory networksR35GM145279 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Chaolin Zhang · 2022 to 2026
$4.6M
RNA Regulatory Networks in Neuronal Cell Type Diversity and FunctionR01NS125018 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Chaolin Zhang · 2022 to 2026
$3.0M
Single-nucleotide resolution mapping of allelic protein-RNA interactions and splicing-regulatory variantsR01GM124486 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHANG, CHAOLIN · 2018 to 2021
$1.8M
Integrative analysis of tissue-specific alternative splicing regulation under adaptive selectionR01GM136856 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHANG, CHAOLIN · 2021 to 2022
$1.0M
NIGMS NIH HHS R01 GM124486NIGMS NIH HHS R01 GM136856NIGMS NIH HHS R35 GM145279NINDS NIH HHS R01 NS125018
6 · The paper itself

Abstract

The specification of synaptic properties is fundamental for the function of neuronal circuits. "Terminal selector" transcription factors coordinate terminal gene batteries that specify cell-type-specific properties. Moreover, pan-neuronal splicing regulators have been implicated in directing neuronal differentiation. However, the cellular logic of how splicing regulators instruct specific synaptic properties remains poorly understood. Here, we combine genome-wide mapping of mRNA targets and cell-type-specific loss-of-function studies to uncover the contribution of the RNA-binding protein SLM2 to hippocampal synapse specification. Focusing on pyramidal cells and somatostatin (SST)-positive GABAergic interneurons, we find that SLM2 preferentially binds and regulates alternative splicing of transcripts encoding synaptic proteins. In the absence of SLM2, neuronal populations exhibit normal intrinsic properties, but there are non-cell-autonomous synaptic phenotypes and associated defects in a hippocampus-dependent memory task. Thus, alternative splicing provides a critical layer of gene regulation that instructs specification of neuronal connectivity in a trans-synaptic manner.

Indexed as

Alternative SplicingNeuronsHippocampusInterneuronsPyramidal CellsSynapsesalternative splicingautismCP: NeuroscienceKHDRBS3neurexinneurodevelopmental disorderneuroliginobject recognitionsynapse formationsynaptic plasticity

Identifiers

PMID36862556
PMCPMC10066595
OpenAlexW4322618042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.